| Back
| Most Recent
2005D-0062:
Draft Guidance FDAs Drug Watch for Emerging Drug Safety
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| C15
|
| 08/09/2005
|
| 07/29/2005
|
| Drug Industry
|
| Pharmiceutics, LLC
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| A. Leander Fontaine, MD
|
|
|
|
|
| C16
|
| 08/09/2005
|
| 08/05/2005
|
| Association
|
| NAtional Eczema Association
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Vicki Kalabokes
|
|
|
|
|
| C17
|
| 08/12/2005
|
| 08/11/2005
|
| Drug Industry
|
| Bristol-Myers Squibb
(BMS)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Richard L. Wolgemuth, PhD
|
|
|
|
|
| EMC2
|
| 08/08/2005
|
| 08/08/2005
|
| Association
|
| Consumer
Healthcare Products Association (CHPA)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| Paul J. Larsen, Esq
|
|
|
| EMC3
|
| 08/08/2005
|
| 08/08/2005
|
| Drug Industry
|
| Pfizer, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Gretchen S. Dieck, PhD
|
|
|
| EMC4
|
| 08/08/2005
|
| 08/08/2005
|
| Device Industry
|
| Biotechnology Industry
Organization (BIO)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Sara Radcliffe, MPH
| |
Top | Back
| Most Recent
Page last updated
August 30, 2005
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
